Monoclonal Human Antibodies That Recognise the Exposed N and C Terminal Regions of the Often-Overlooked SARS-CoV-2 ORF3a Transmembrane Protein

ORF3a has been identified as a viroporin of SARS-CoV-2 and is known to be involved in various pathophysiological activities including disturbance of cellular calcium homeostasis, inflammasome activation, apoptosis induction and disruption of autophagy. ORF3a-targeting antibodies may specifically and...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Tyng Hwey Tan, Elizabeth Patton, Carol A. Munro, Dora E. Corzo-Leon, Andrew J. Porter, Soumya Palliyil
Formato: article
Lenguaje:EN
Publicado: MDPI AG 2021
Materias:
Acceso en línea:https://doaj.org/article/c10c6e519e564d23bd7c3db95d5ae027
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:c10c6e519e564d23bd7c3db95d5ae027
record_format dspace
spelling oai:doaj.org-article:c10c6e519e564d23bd7c3db95d5ae0272021-11-25T19:13:18ZMonoclonal Human Antibodies That Recognise the Exposed N and C Terminal Regions of the Often-Overlooked SARS-CoV-2 ORF3a Transmembrane Protein10.3390/v131122011999-4915https://doaj.org/article/c10c6e519e564d23bd7c3db95d5ae0272021-11-01T00:00:00Zhttps://www.mdpi.com/1999-4915/13/11/2201https://doaj.org/toc/1999-4915ORF3a has been identified as a viroporin of SARS-CoV-2 and is known to be involved in various pathophysiological activities including disturbance of cellular calcium homeostasis, inflammasome activation, apoptosis induction and disruption of autophagy. ORF3a-targeting antibodies may specifically and favorably modulate these viroporin-dependent pathological activities. However, suitable viroporin-targeting antibodies are difficult to generate because of the well-recognized technical challenge associated with isolating antibodies to complex transmembrane proteins. Here we exploited a naïve human single chain antibody phage display library, to isolate binders against carefully chosen ORF3a recombinant epitopes located towards the extracellular N terminal and cytosolic C terminal domains of the protein using peptide antigens. These binders were subjected to further characterization using enzyme-linked immunosorbent assays and surface plasmon resonance analysis to assess their binding affinities to the target epitopes. Binding to full-length ORF3a protein was evaluated by western blot and fluorescent microscopy using ORF3a transfected cells and SARS-CoV-2 infected cells. Co-localization analysis was also performed to evaluate the “pairing potential” of the selected binders as possible alternative diagnostic or prognostic biomarkers for COVID-19 infections. Both ORF3a N and C termini, epitope-specific monoclonal antibodies were identified in our study. Whilst the linear nature of peptides might not always represent their native conformations in the context of full protein, with carefully designed selection protocols, we have been successful in isolating anti-ORF3a binders capable of recognising regions of the transmembrane protein that are exposed either on the “inside” or “outside” of the infected cell. Their therapeutic potential will be discussed.Tyng Hwey TanElizabeth PattonCarol A. MunroDora E. Corzo-LeonAndrew J. PorterSoumya PalliyilMDPI AGarticleSARS-CoV-2ORF3aviroporinrecombinant antibodiesanti-ORF3a mAbsMicrobiologyQR1-502ENViruses, Vol 13, Iss 2201, p 2201 (2021)
institution DOAJ
collection DOAJ
language EN
topic SARS-CoV-2
ORF3a
viroporin
recombinant antibodies
anti-ORF3a mAbs
Microbiology
QR1-502
spellingShingle SARS-CoV-2
ORF3a
viroporin
recombinant antibodies
anti-ORF3a mAbs
Microbiology
QR1-502
Tyng Hwey Tan
Elizabeth Patton
Carol A. Munro
Dora E. Corzo-Leon
Andrew J. Porter
Soumya Palliyil
Monoclonal Human Antibodies That Recognise the Exposed N and C Terminal Regions of the Often-Overlooked SARS-CoV-2 ORF3a Transmembrane Protein
description ORF3a has been identified as a viroporin of SARS-CoV-2 and is known to be involved in various pathophysiological activities including disturbance of cellular calcium homeostasis, inflammasome activation, apoptosis induction and disruption of autophagy. ORF3a-targeting antibodies may specifically and favorably modulate these viroporin-dependent pathological activities. However, suitable viroporin-targeting antibodies are difficult to generate because of the well-recognized technical challenge associated with isolating antibodies to complex transmembrane proteins. Here we exploited a naïve human single chain antibody phage display library, to isolate binders against carefully chosen ORF3a recombinant epitopes located towards the extracellular N terminal and cytosolic C terminal domains of the protein using peptide antigens. These binders were subjected to further characterization using enzyme-linked immunosorbent assays and surface plasmon resonance analysis to assess their binding affinities to the target epitopes. Binding to full-length ORF3a protein was evaluated by western blot and fluorescent microscopy using ORF3a transfected cells and SARS-CoV-2 infected cells. Co-localization analysis was also performed to evaluate the “pairing potential” of the selected binders as possible alternative diagnostic or prognostic biomarkers for COVID-19 infections. Both ORF3a N and C termini, epitope-specific monoclonal antibodies were identified in our study. Whilst the linear nature of peptides might not always represent their native conformations in the context of full protein, with carefully designed selection protocols, we have been successful in isolating anti-ORF3a binders capable of recognising regions of the transmembrane protein that are exposed either on the “inside” or “outside” of the infected cell. Their therapeutic potential will be discussed.
format article
author Tyng Hwey Tan
Elizabeth Patton
Carol A. Munro
Dora E. Corzo-Leon
Andrew J. Porter
Soumya Palliyil
author_facet Tyng Hwey Tan
Elizabeth Patton
Carol A. Munro
Dora E. Corzo-Leon
Andrew J. Porter
Soumya Palliyil
author_sort Tyng Hwey Tan
title Monoclonal Human Antibodies That Recognise the Exposed N and C Terminal Regions of the Often-Overlooked SARS-CoV-2 ORF3a Transmembrane Protein
title_short Monoclonal Human Antibodies That Recognise the Exposed N and C Terminal Regions of the Often-Overlooked SARS-CoV-2 ORF3a Transmembrane Protein
title_full Monoclonal Human Antibodies That Recognise the Exposed N and C Terminal Regions of the Often-Overlooked SARS-CoV-2 ORF3a Transmembrane Protein
title_fullStr Monoclonal Human Antibodies That Recognise the Exposed N and C Terminal Regions of the Often-Overlooked SARS-CoV-2 ORF3a Transmembrane Protein
title_full_unstemmed Monoclonal Human Antibodies That Recognise the Exposed N and C Terminal Regions of the Often-Overlooked SARS-CoV-2 ORF3a Transmembrane Protein
title_sort monoclonal human antibodies that recognise the exposed n and c terminal regions of the often-overlooked sars-cov-2 orf3a transmembrane protein
publisher MDPI AG
publishDate 2021
url https://doaj.org/article/c10c6e519e564d23bd7c3db95d5ae027
work_keys_str_mv AT tynghweytan monoclonalhumanantibodiesthatrecognisetheexposednandcterminalregionsoftheoftenoverlookedsarscov2orf3atransmembraneprotein
AT elizabethpatton monoclonalhumanantibodiesthatrecognisetheexposednandcterminalregionsoftheoftenoverlookedsarscov2orf3atransmembraneprotein
AT carolamunro monoclonalhumanantibodiesthatrecognisetheexposednandcterminalregionsoftheoftenoverlookedsarscov2orf3atransmembraneprotein
AT doraecorzoleon monoclonalhumanantibodiesthatrecognisetheexposednandcterminalregionsoftheoftenoverlookedsarscov2orf3atransmembraneprotein
AT andrewjporter monoclonalhumanantibodiesthatrecognisetheexposednandcterminalregionsoftheoftenoverlookedsarscov2orf3atransmembraneprotein
AT soumyapalliyil monoclonalhumanantibodiesthatrecognisetheexposednandcterminalregionsoftheoftenoverlookedsarscov2orf3atransmembraneprotein
_version_ 1718410180857692160